During the past decade, Sockolov and Sockolov APC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sockolov and Sockolov APC" are "Chronic Obstructive Pulmonary Disease" (1 trials) and "Overactive Bladder" (1 trials). Many other conditions were trialed in "Sockolov and Sockolov APC" in a lesser frequency.

Most popular intervention types in "Sockolov and Sockolov APC" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Arformoterol" (1 trials), "Fesoterodine 4mg" (1 trials) and "Fesoterodine 8mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sockolov and Sockolov APC" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Sockolov and Sockolov APC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Sockolov and Sockolov APC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sockolov and Sockolov APC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".